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Sirtuins are known to protect cells and extend life
span, but our previous studies indicated that S. cer-
evisiae Sir2 can also increase stress sensitivity and
limit life-span extension. Here we provide evidence
for a role of the mammalian Sir2 ortholog SirT1 in
the sensitization of neurons to oxidative damage.
SirT1 inhibition increased acetylation and decreased
phosphorylation of IRS-2; it also reduced activation
of the Ras/ERK1/2 pathway, suggesting that SirT1
may enhance IGF-I signaling in part by deacetylating
IRS-2. Either the inhibition of SirT1 or of Ras/ERK1/2
was associated with resistance to oxidative damage.
Markers of oxidized proteins and lipids were reduced
in the brain of old SirT1-deficient mice, but the life
span of the homozygote knockout mice was reduced
under both normal and calorie-restricted conditions.
These results are consistent with findings in S. cere-
visiae and other model systems, suggesting that
mammalian sirtuins can play both protective and
proaging roles.
INTRODUCTION
Sirtuins, or Sir2 family proteins, are NAD+-dependent class III
histone deacetylases conserved from bacteria to humans
(Frye, 2000). Sir2 modulates aging and life span in yeast,
C. elegans, and Drosophila (Fabrizio et al., 2005; Kaeberlein
et al., 1999; Rogina and Helfand, 2004; Tissenbaum and
Guarente, 2001). Though earlier studies showed the antiaging
effect of Sir2 and its function in calorie restriction (CR) in lower
eukaryotes, later studies found that Sir2 is not required for
CR-induced life-span extension in yeast (Kaeberlein et al.,
2004) or worms (Hansen et al., 2007; Kaeberlein et al., 2006;
Lee et al., 2006). Notably, our lab showed that lack of Sir2 in
yeast further extended the life span of calorie-restricted cells,
long-lived Sch9 (Fabrizio et al., 2005), or of mutants with defi-
ciencies in the Ras/cAMP pathway, suggesting that Sir2 can
also promote aging. SirT1, the mammalian ortholog of yeast
Sir2, has been shown to regulate numerous physiological pro-
cesses including glucose metabolism, DNA repair, and apopto-38 Cell Metabolism 8, 38–48, July 2008 ª2008 Elsevier Inc.sis (Bordone et al., 2006; Cohen et al., 2004; Luo et al., 2001;
Moynihan et al., 2005; Rodgers et al., 2005; Sun et al., 2007).
In mammalian cells, SirT1 regulates several stress-response fac-
tors, such as p53 tumor suppressor (Langley et al., 2002; Vaziri
et al., 2001), forkhead transcription factors (Brunet et al., 2004;
Motta et al., 2004), and NF-kB (Yeung et al., 2004); yet it remains
unclear if/how SirT1 regulates resistance to oxidative stress.
Notably, SirT1 is expressed at a high level in the brain compared
to other organs (Michishita et al., 2005).
Here we studied primary rat cortical neurons and other mam-
malian cells to test the role of SirT1 in stress resistance. Our re-
sults indicate that the role of SirT1 deficiency in protecting
against oxidative damage is eclipsed by the important role of
this deacetylase in many normal functions.
RESULTS
Inhibition of SirT1 Increases Oxidative Stress
Resistance in Neurons
Previous studies in our lab showed that deletion of SIR2 in-
creases stress resistance in S. cerevisiae (Fabrizio et al., 2005).
Here we investigated whether SirT1, the ortholog of yeast Sir2,
plays a similar role in mammalian cells. Oxidative stress was in-
duced in cultured rat neurons by hydrogen peroxide (H2O2) or
menadione, which generates both superoxide and H2O2. Cell vi-
ability was measured by MTT assay. Ten days in vitro (DIV) cor-
tical neuron cultures were incubated with 400 mMH2O2 or 7.5 mM
menadione for 24 hr followed by MTT assay. After H2O2 treat-
ment, about 26% of the neurons survived, whereas 50% sur-
vived menadione treatment (Figures 1A–1D). We also pretreated
neurons with SirT1 inhibitors, nicotinamide (Nico), or sirtinol for
48 hr and then subjected them to the above oxidative-stress
protocol. Nicotinamide dose dependently increased neuronal
survival after H2O2 treatment. Five-hundred mM and five mM
of Nico pretreatment increased the survival of H2O2-treated
cells to 52.3 ± 4.7% (p < 0.01, H2O2 versus H2O2 + 500 mM
Nico, n = 3, one-way ANOVA, Turkey’s test) and 58.7 ± 2.3%
(p < 0.001, H2O2 versus H2O2 + 5 mM Nico, n = 3, one-way
ANOVA, Turkey’s test), respectively (Figure 1A), while 10 mM
(p > 0.05, H2O2 versus H2O2 + 10 mM Nico, n = 3, one-way
ANOVA, Turkey’s test) and 100 mM (p > 0.05, H2O2 versus
H2O2 + 100 mM Nico, n = 3, one-way ANOVA, Turkey’s test) of
Nico showed no improvement. Nico also dose dependently
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SirT1 Sensitizes Neurons by Activating IRS-2/ERKFigure 1. Inhibiting SirT1 Deacetylase Increases Oxidative Stress Resistance in Neurons
(A–D) Ten to fourteen DIV neurons were treated with nicotinamide (A and B; Nico) or sirtinol (C and D) at indicated concentrations for 48 hr. Oxidative stress was
then induced by 400 mMof hydrogen peroxide (A and C) or 7.5 mM of menadione (B and D), respectively. Twenty-four hr later, cell viability was measured by MTT
assay. The absorbance values are normalized to respective controls (H2O2/menadione relative to vehicle-treated control; H2O2 + Nico/sirtinol relative to Nico/
sirtinol alone; menadione + Nico/sirtinol relative to Nico/sirtinol alone).
(E) Five DIV neurons were transfected with control or SirT1 siRNA. Two days later, neurons were subjected to H2O2 or menadione, followed by MTT assay 24 hr
later.
(F) Five DIV neurons were transfected with control or SirT1 siRNA, and 2 days later, SirT1 deacetylase activity was measured. Data represent mean ± SEM.
Cortical neurons were cultured in 96-well plates (A–E) or 10 cm dishes (F).rescued neurons in menadione-induced oxidative stress (Fig-
ure 1B). Five-hundred mM and five mM Nico increased the
survival of menadione-treated cells to 77.0 ± 2.2% (p < 0.01,
menadione versus menadione + 500 mM Nico, n = 3, one-way
ANOVA, Turkey’s test) and 86.1 ± 2.4% (p < 0.001, menadione
versus menadione + 5 mM Nico, n = 3, one-way ANOVA,
Turkey’s test), respectively, while 10 mM (p > 0.05, menadione
versusmenadione + 10mMNico, n = 3, one-wayANOVA, Turkey’s
test) and 100 mM (p > 0.05, menadione versus menadione +
100 mM nicotinamide, n = 3, one-way ANOVA, Turkey’s test) of
Nico showed no significant effect. These values were adjusted
to the effect of Nico alone (Nico alone was not significantly
different from control; Figure S1).
Similar effects were achieved with another SirT1 inhibitor
sirtinol. Twenty-five mM and fifty mM of sirtinol pretreatment
increased the survival of H2O2-treated neurons to 49.4 ± 3.6%
(p < 0.01, H2O2 versus H2O2 + 25 mM sirtinol, n = 3, one-way
ANOVA, Turkey’s test) and 70.4 ± 1.2% (p < 0.001, H2O2 versus
H2O2 + 50 mM sirtinol, n = 3, one-way ANOVA, Turkey’s test),
respectively (Figures 1C and 1D), while 5 mM sirtinol (p > 0.05,
H2O2 versus H2O2 + 5 mM sirtinol, n = 3, one-way ANOVA,
Turkey’s test) showed no benefit. Sirtinol also dose dependently
increased neuronal survival in menadione-induced oxidative
stress. Twenty-five mM and fifty mM of sirtinol pretreatment
increased the viability of menadione-treated cells to 86.7 ±
5.7% (p < 0.01, H2O2 versus H2O2 + 25 mM sirtinol, n = 3, one-
way ANOVA, Turkey’s test) and 93.4 ± 1.9% (p < 0.01, H2O2
versus H2O2 + 50 mM sirtinol, n = 3, one-way ANOVA, Turkey’s
test), respectively, whereas 5 mM of sirtinol (p > 0.05, H2O2versus H2O2 + 5 mM sirtinol, n = 3, one-way ANOVA, Turkey’s
test) showed no effect. The absorbance values are adjusted
to the effects of sirtinol alone (sirtinol decreased MTT
reduction by 13%–21% at 25–50 mM compared to control)
(Figure S1).
To confirm that the stress resistance is caused by reduced
SirT1 activity, we transfected either control or SirT1 siRNA into
five DIV neurons and assessed survival after H2O2- or menadi-
one-induced oxidative stress (Figure 1E).
Knockdown of SirT1 increased the viability of H2O2-treated
cells from 26.2 ± 2.7% to 57.5 ± 3.7% (p < 0.001, H2O2 versus
H2O2 + SirT1 siRNA, n = 4, t test). Inhibition of SirT1 also boosted
the survival of menadione-treated cells from 54.2 ± 2.7% to
78.5 ± 3.7% (p < 0.01, menadione versus menadione + SirT1
siRNA, n = 4, t test). Viability of SirT1 siRNA-treated cells did
not differ from that of control. To confirm that SirT1 was indeed
knocked down by siRNA, we initially attempted to examine pro-
tein expression; however, none of the commercial SirT1 anti-
bodies we have tried (05-707 Anti-Sirt1; 07-131 Anti-Sir2; Milli-
pore, Billerica, MA) appear to bind specifically to SirT1 in rat
neurons. Hence, we carried out SirT1 deacetylase activity assay
using a fluorometric kit 2days after transfection (Figure 1F). SirT1
siRNA decreased SirT1 deacetylase activity to 53.2 ± 4.2% of
control (p < 0.01, n = 4, control versus SirT1 siRNA, t test). Con-
sistent with our research in yeast, these results in neurons sug-
gest that inhibiting SirT1 can protect against oxidative stress.
Since IGF-I/Akt pathway has been shown to both protect and
sensitize cells against oxidative damage (Kops et al., 2002; Song
et al., 2005), we tested whether Akt phosphorylation wasCell Metabolism 8, 38–48, July 2008 ª2008 Elsevier Inc. 39
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(Figure S5A), which suggests that the effect of SirT1 inhibition
is unlikely to be mediated by the Akt pathway.
SirT1 Inhibition Decreases Ras/ERK Activation
in Culture and In Vivo
Neuronal Ras/ERK (extracellular signal-regulated kinase) is ama-
jor pathway regulating oxidative stress. In our yeast studies we
described the Ras pathway as a second proaging pathway in
parallel to the Sch9 pathway (Fabrizio et al., 2003; 2004). Dele-
tion of SIR2 in yeast further increased stress resistance in mu-
tants lacking SCH9 but not in those with reduced Ras/cAMP sig-
naling (Fabrizio et al., 2005), raising the possibility that Sir2 may
regulate components of the Ras/cAMP pathway. Based on our
yeast results and because mammalian Ras functions down-
stream of the proaging IGF-I receptor, we studied the role of
SirT1 inhibitors on Ras/ERK signaling. Neurons cultured in neu-
robasal media supplemented with B27 (containing 4 mg/ml in-
sulin) showed a high-basal activation of Ras (GTP-bound Ras),
which was reduced by a 4 hr treatment of 60 mM of sirtinol (Fig-
ure 2A), indicating that SirT1 modulates Ras activity.
We also checked if ERK1/2, a major effector of Ras, is altered
by SirT1 inhibition. Ten to fourteen DIV rat cortical neurons were
treated with vehicle, SirT1 inhibitors Nico for 48 hr or sirtinol for
4 hr, and cell lysates were collected for SDS-PAGE and blotted
with anti-phospho-ERK1/2 (P-ERK1/2) and anti-ERK1/2, re-
spectively. Ten mM and twenty-five mM of Nico decreased
phosphorylated ERK1/2 (Figure 2B). The effect of sirtinol was
dose dependent as 30 mM of sirtinol reduced the ratio of
P-ERK/ERK by 45% and 60 mM of sirtinol reduced the ratio by
68% (Figures 2C and 2D) (p < 0.05, control versus sirtinol
30 mM; p < 0.01, control versus sirtinol 60 mM; n = 4, one-way
ANOVA, Turkey’s test).
To confirm that the above effects are due to specific inhibition
of SirT1, a plasmid encoding SirT1 siRNAwas cotransfectedwith
GFP in neurons. This plasmid has been shown to reduce SirT1
expression (Cohen et al., 2004). Forty-eight hours after transfec-
tion, the cells were immunostained with anti-P-ERK1/2 and anti-
GFP (Figure 2E). The immunodensity of P-ERK1/2 in transfected
cells was significantly lower than that of surrounding nontrans-
fected cells (p < 0.05, n = 12, Student’s t test). As a control,
a plasmid encoding a dominant-negative SirT2, GFP-SirT2,
was transfected into neurons. P-ERK1/2 staining remained the
same in SirT2DN-transfected cells compared to nontransfected
ones (p > 0.05, n = 12, Student’s t test) (Figure 2F). These data
confirm that SirT1 inhibition attenuates the activation of ERK1/
2. We also checked whether the same occurs in vivo and indeed
a decrease in ERK1/2 activationwas observed in the hippocampi
of 17-day-old SirT1 knockout (KO) mice (p < 0.05, SirT1+/+ ver-
sus SirT1/, n = 6, t test) (Figures 2G and 2H). Together, these
data suggest that inhibition of SirT1 can downregulate ERK1/2
activity.
We also tested whether the effect of SirT1 on ERK1/2 is ob-
served in a human cell line and whether it inhibits IGF-I signaling.
HEK293 cells were serum starved for 15 hr and treated with IGF-I
(500 ng/ml) for 5 min. Cell lysates were immediately collected for
SDS-PAGE and immunoblotted for P-ERK or ERK (Figures 2I
and 2J). Starved cells showed low levels of P-ERK1/2, and
IGF-I induced a 12-fold increase in P-ERK1/2 (p < 0.01, control40 Cell Metabolism 8, 38–48, July 2008 ª2008 Elsevier Inc.versus IGF-I, n = 3, one-way ANOVA, Turkey’s test). Four hr pre-
treatment of 60 mM sirtinol markedly reduced this effect of IGF-I
on ERK1/2 phosphorylation (60% decrease, p < 0.05, IGF-I ver-
sus IGF-I + sirtinol, n = 3, one-way ANOVA, Turkey’s test). To be-
gin to determine how SirT1 inhibition affects ERK activation, we
applied PMA (phorbol 12-myristate 13-acetate, a phorbol ester,
1 mg/ml), which is known to activate ERK1/2 through the PKC/
Raf-1/MEK1 pathway (Liebmann, 2001), to starved cells. As ex-
pected, it induced a 24-fold increase in P-ERK1/2 (p < 0.001,
control versus PMA, n = 3, one-way ANOVA, Turkey’s test) (Fig-
ures 2K and 2L). However, pretreatment with sirtinol did not
block this effect (p > 0.05, PMA versus PMA + sirtinol, n = 3,
one-way ANOVA, Turkey’s test), indicating that the target mole-
cule(s) of SirT1 lie(s) between insulin/IGF-IR and Ras.
Subcellular Localization of SirT1 in the Brain
For SirT1 to regulate the activation of Ras/ERK, SirT1 may either
regulate the gene expression of upstream molecules or act di-
rectly upon those molecules through posttranslational modifica-
tion. SirT1 had long been considered a nuclear protein until re-
cently (Tanno et al., 2007). The subcellular localization of SirT1
in neuronal cells is poorly understood. We investigated the pos-
sibility that SirT1 acts on nonnuclear substrates by examining its
localization in mouse brains (Figure 3). Brains from postnatal day
3 (P3, Figure 3A) and adult (Figure 3B) mice were collected, ho-
mogenized, and separated into nuclear, cytosol, and membrane
fractions through sucrose-gradient centrifugation. These frac-
tions were then immunoblotted for SirT1, NeuN (as a nucleus
marker), GAPDH (as a cytosol marker), and GluR2/3 (a mem-
brane-associated protein). SirT1 antibody recognizes one band
at 110 kDa, which is absent from the brain of SirT1 KO mice
(Figure 3C), confirming the specificity of the signal. In P3 brains,
SirT1 is localized to both nuclear and cytosolic fraction with the
majority residing in the cytosol, whereas, in the adult brain, it is
foundpredominantly in the cytosolic fraction (Figures 3A and 3B).
Increased Acetylation and Decreased Phosphorylation
of IRS-2 by SirT1 Inhibition
The localization of SirT1 to the cytosol could allow direct deace-
tylation of substrate protein(s) in the cytosol. The signaling path-
way upstream of Ras is composed of sequential activation of
receptors, insulin receptor substrates (IRS), or Shc, Grb2, and
SOS. Among the signaling molecules between insulin/IGF-I
receptors and Ras, IRS-1 has been shown to be an acetylated
protein (Kaiser and James, 2004). Therefore, we hypothesized
that SirT1 may regulate insulin/IGF-I signal transduction by
deacetylating IRS. To test this hypothesis, we first conducted
coimmunoprecipitation to see whether SirT1 physically interacts
with IRS-1 or IRS-2. HEK293 cells were transfected with a plas-
mid encoding V5-tagged SirT1, and cell lysates were immuno-
precipitated with anti-V5 or control IgG and probed for IRS-1
or IRS-2, respectively (Figure 4A). IRS-2, but not IRS-1, coimmu-
noprecipitated with V5-SirT1, suggesting that IRS-2 might be
a substrate of SirT1. To determine whether SirT1 can directly
deacetylate IRS-2, we set up an in vitro deacetylation experi-
ment. We immunoprecipitated IRS-2 from HEK293 cells and
incubated equal amounts of purified IRS-2 with different doses
of SirT1 and 1 mM of NAD for 1.5 hr, then, we blotted for acety-
lated-lysine (AcK) or IRS-2 (Figure 4B). This experiment
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acetylate IRS-2 in a cell-free system in agreement with a recent
finding (Zhang, 2007).
Next we examined if SirT1 could deacetylate IRS-1 or IRS-2 in
live cells and if this deacetylation affects IGF-I signaling. HEK
cells were serum starved (0.5% FBS) for 15 hr and treated with
500 ng/ml of IGF-I for 5 min. IRS-1 or IRS-2 were immunoprecip-
itated from the cells and probed with anti-AcK (Figures 4C, 4D,
and S7). IGF-I did not significantly alter the acetylation level of
IRS-1 or IRS-2 (Figure 4D). However, pretreatment with 5 mM
of Nico for 24 hr or 60 mMof sirtinol for 4 hr significantly increased
the acetylation level of IRS-2 by 93.5% or 79.7%, respectively
Figure 2. Inhibition of SirT1 Deacetylase Decreases Ras/ERK1/2 Activation in Cultured Neurons and In Vivo
(A) Representative blots showing the effect of SirT1 inhibitor sirtinol on Ras activation. Ten to fourteen DIV neurons were treated with vehicle or 60 mM sirtinol for
4 hr and subjected to Ras activation assay or immunoblotted with anti-Ras.
(B and C) Representative blots showing the effect of SirT1 inhibitors nicotinamide (B) and sirtinol (C) on ERK1/2 signaling. Ten to fourteen DIV neurons were
treatedwith Nico for 48 hr or sirtinol for 4 hr. Total cell lysates were collected for SDS-PAGE and blottedwith anti-phospho-ERK1/2 and anti-ERK1/2, respectively.
(D) Quantification of immunoblots showing the effect of sirtinol on ERK1/2 activation.
(E) Seven DIV cortical neurons were transfected with U6Pro-SirT1-siRNA+GFP or dominant-negative GFP-SirT2 (SirT2DN); 48 hr later, they were immunostained
with anti-phospho-ERK1/2.
(F) Quantification of immunodensity from 12 transfected and 12 nearby nontransfected cells for SirT1 siRNA and SirT2DN, respectively.
(G and H) Representative blots (G) and quantification (H) showing the effect of SirT1 deacetylase on ERK1/2 signaling in mice hippocampi.
(I–L) Representative blots (I and K) and quantification (J and L) showing the effect of sirtinol on ERK1/2 signaling in HEK cells. HEK cells were starved for 15 hr in
media containing 0.5%FBS and incubated with 60 mMsirtinol for 4 hr and then treated with IGF-1 or PMA for 5min. Cell lysateswere subjected to SDS-PAGE and
blotted with anti-phospho-ERK1/2 or anti-ERK1/2. Quantifications are shown as mean ± SEM.
Cell Metabolism 8, 38–48, July 2008 ª2008 Elsevier Inc. 41
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IGF-I + sirtinol, n = 4, one-way ANOVA, Turkey’s test) but had
no effect on IRS-1. To study whether the alteration of the acety-
lation level of IRS-2 affects its signaling, we measured its phos-
phorylation level. Serum-starved HEK cells were treated with
IGF-I with or without SirT1 inhibitors, and IRS-2 was immunopre-
cipitated from the cells and probed for phosphotyrosine (PY).
IGF-I induced a 14-fold increase in phosphorylation of IRS-2,
which was significantly diminished by pretreatment with Nico
(46.7% decrease, p < 0.05, IGF-I versus IGF-I + Nico, n = 4,
one-way ANOVA, Turkey’s test) or sirtinol (55.3% decrease,
p < 0.05, IGF-I versus IGF-I + sirtinol, n = 4, one-way ANOVA,
Turkey’s test).
To corroborate the results in HEK293 cells, we also examined
rat cortical neurons transfected with control or SirT1 siRNA
(Figure 4E). Inhibition of SirT1 increased acetylation level of
IRS-2 and decreased phosphorylation of IRS-2. Concurrently,
activation of ERK1/2 was reduced by SirT1 inhibition.
Figure 3. Subcellular Localization of SirT1 in the Brain
(A and B) Forebrains from postnatal 3 days (P3, A; adult mice, B) were homogenized and separated into nuclear, cytosol, and membrane fractions through
sucrose-gradient centrifugation and immunoblotted with SirT1, NeuN, GAPDH, and GluR2/3, respectively. In P3, brain SirT1 is localized in both nucleus and
cytosol, while it is found predominantly in cytosol in the adult brain.
(C) The specificity of SirT1 immunoblot was confirmed with SirT1/ mice.
Figure 4. SirT1 Regulates Ras/ERK1/2 Signaling via Deacetylation of IRS-2
(A) Physical interaction between SirT1 and IRS-2. HEK293 cells were transfected with V5-SirT1, and 48 hr later cell lysates were immunoprecipitated with V5
antibody or control IgG and probed with anti-IRS-1 or anti-IRS-2, respectively.
(B) SirT1 deacetylates IRS-2 in vitro. HEK cell lysates were precipitated with anti-IRS-2, divided into three equal parts, and incubated with 0, 1, or 2 mg SirT1
deacetylase, respectively, for 1.5 hr. They were then subjected to SDS-PAGE and blotted with antiacetylated lysine (AcK).
(C and D) Representative blots (C) and quantification (D) showing that inhibition of SirT1 deacetylase in HEK cells increased acetylation of IRS-2 and decreased
phosphorylation of IRS-2 while having no effect on IRS-1. In (C), HEK cells were treated as indicated and cell lysates were precipitated with anti-IRS-1 or anti-IRS-
2 and blotted with anti-AcK or anti-phosphotyrosine (PY). Cell lysates were also blotted for IRS-1 or IRS-2. In (D), quantification is shown from four to five blots
(mean ± SEM).
(E) Representative blots showing the effect of SirT1 on IRS-2 deacetylation in neurons. Five DIV neurons were transfected with either control or SirT1 siRNA. Two
days later, cell lysates were immunoprecipitated with anti-IRS-2 and blotted for AcK or PY. Cell lysates were also blotted for IRS-2, P-ERK1/2, and ERK1/2,
respectively.
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Oxidative Stress
To test if downregulation of ERK1/2 can account for the effect of
SirT1 inhibition on stress resistance, we applied MEK1/2 (imme-
diately upstream of ERK1/2) inhibitors to cultured neurons. Oxi-
dative stresswas induced byH2O2 or 7.5 mMofmenadione for 24
hr. The indicated groups of cells were pretreatedwithMEK1/2 in-
hibitor—10 mM U0126 or 10 mM SL327 for 4 hr. MTT assay sug-
gests that 400 mM H2O2 killed 71.4% ± 5.4% of neurons
(Figure 5A). Pretreatment with U0126 or SL327 increased the
survival to 45.9% ± 4.5% (p > 0.05, H2O2 versus H2O2 + U, n = 3,
one-way ANOVA, Turkey’s test) or 49.2% ± 5.5% (p < 0.05,
H2O2 versus H2O2 + SL, n = 3, one-way ANOVA, Turkey’s test),
respectively. Menadione reduced the viability to 49.9% ± 5.3%
compared to control. Pretreatment of U0126 or SL327 increased
the survival to 73.9% ± 3.7% (p < 0.05, menadione versus men-
adione + U, n = 3, one-way ANOVA, Turkey’s test) or 68.3% ±
1.5% (p > 0.05, menadione versus menadione + SL, n = 3,
one-way ANOVA, Turkey’s test), respectively. Similar results
were obtained with Live/Dead assay (Figures 5B and 5C). One-
hundred mM of H2O2 led to 57.5% ± 3.3% survival compared
to control. Pretreatment of U0126 increased viability to 74.4%
± 3.5% (p < 0.05, H2O2 versus H2O2 + U, n = 4, one-way ANOVA,
Turkey’s test), and SL327 increased survival to 74.1% ± 3.6%
(p < 0.05, H2O2 versus H2O2 + SL, n = 4, one-way ANOVA,
Turkey’s test). Similarly, menadione reduced viability to
52.1% ± 2.6% compared to control. Pretreatment of U0126
increased viability to 65.8% ± 3.8% (p > 0.05, menadione versus
menadione + U, n = 4, one-way ANOVA, Turkey’s test), while
SL327 increased survival to 69.4% ± 2.6% (p < 0.05, menadione
versus menadione + SL, n = 4, one-way ANOVA, Turkey’s test).
Thus, inhibition of MEK1/ERK1/2 is sufficient to increase the
stress resistance of neurons, suggesting that SirT1 can sensitize
neurons to oxidative stress at least in part by upregulating ERK1/
2 activity.
As both SirT1 and ERK1/2 are involved in the regulation of ap-
optosis, we studied how inhibition of SirT1 or ERK1/2 affects ap-
optosis in our system. We transfected neurons with SirT1 siRNA
Figure 5. Inhibiting MEK/ERK1/2 Protects Neurons against Oxidative Stress
Neurons were cultured in 96-well plates (A, D, and E) or glass coverslips in 6-well plates (B).
Ten to fourteen DIV neurons were pretreated with ERK1/2 inhibitors U0126 or SL327 for 4 hr. Oxidative stress was induced by H2O2 or menadione. Viability was
measured by MTT (A) or live/dead assay (B).
(C) Percent live was calculated from the number of live (green) and dead (red) cells.
(D and E) ERK1/2 inhibition primarily attenuates necrosis. Neurons were transfected with control or SirT1 siRNA, or incubated with SL327 before exposed to
400 mM H2O2 or 7.5 mM menadione. Twenty-four hr later, culture media were collected for LDH assay, and cells were lysed for apoptosis assay (& p < 0.01
compared with H2O2; # p < 0.05 compared to Md, t test). Data represent mean ± SEM.
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the cells to 400 mM H2O2 or 7.5 mMmenadione for 24 hr. We es-
timated necrosis by measuring LDH (lactate dehydrogenase) re-
lease in the media, and we quantified apoptosis by measuring
cytoplasmic histone-associated mono- and oligonucleosomes
with Cell Death Detection ELISAPLUS kit (Figures 5D and 5E). Hy-
drogen peroxide and menadione increased LDH release to 5.5 ±
0.7- and 4.4 ± 0.4-fold of control, respectively. Inhibition of SirT1
or ERK1/2 significantly alleviated the increase in LDH release
(Figure 5D; p < 0.01 compared to H2O2, p < 0.05 compared to
menadione; n = 3, t test). Meanwhile, H2O2 and menadione
induced apoptosis to 1.6 ± 0.2- and 2.0 ± 0.2-fold of control, re-
spectively. Neither SirT1 nor ERK1/2 inhibition effectively re-
duced H2O2-induced apoptosis, but SirT1 inhibition had a small
yet significant effect in reducing apoptosis induced by menadi-
one (Figure 5E; 1.6 ± 0.2-fold of control, p < 0.05, n = 10, t test).
Reduced Oxidative Damage in SirT1/ Mouse Brain
Wehaveshown inneurons thatSirT1 inhibitionprotectsagainstex-
ogenous oxidative insult of H2O2 or menadione. To determine
whether SirT1 can have similar effects in vivo, we measured
markers of oxidative damage in the brain of 18-month-old mice.
We removed brains (minus cerebellum) from SirT1 +/+ and /
mice and measured protein carbonyl content with an ELISA kit
(Figure 6A) and lipid peroxidation with TBARS method (Fig-
ure 6B). Compared to wild-type (WT) mice (2.3 ± 0.14 nmol/mg),
KO brains showed 17% decrease in protein carbonyl content
(1.9 ± 0.1 nmol/mg; p < 0.05, n = 7, t test). Lipid peroxidation
was also reduced in KO brain (3.7 ± 0.2 nmol malondialde-
hyde/mg), 20% less than that inWT (4.5 ± 0.2 nmol/mg; p < 0.05,
n = 7, t test). The reduction of markers of oxidative stress in SirT1
KO brain is consistent with our findings in culture. Although a re-
cent report discovered that SirT1 protects the heart against ox-
idative stress (Alcendor et al., 2007), these results suggest that
SirT1 may play a different role in the brain and other cells.
We previously showed that lack of Sir2 in yeast extended fur-
ther the life span of CR cells, or long-lived Sch9 but not under
standard nutrient conditions (Fabrizio et al., 2005). Our current
results suggest that SirT1 can also sensitizemammalian neurons
to oxidative damage. To determine the role of SirT1 in vivo, we
monitored the life span of WT mice and those homozygous or
heterozygous (HET) for disruption mutation in the SirT1 gene
(McBurney et al., 2003). The mice were fed ad lib (Figure 6C) or
on a 40% reduced-calorie diet for 2 years (Figure 6D). Compared
to WT and HET mice, SirT1 KO mice survived shorter on both
normal and CR diets. This is in agreement with recent findings
by others (Boily et al., 2008).
DISCUSSION
Sirtuins including Sir2 and SirT1 have been described as media-
tors of the effect of CR on longevity and are widely believed to
Figure 6. Reduced Brain Oxidative Damage and Life Span in SirT1/ Mice
(A and B) Reduced oxidative stress in SirT1 knockout mice brain. In (A), protein carbonyl content; nmol protein carbonyl per mg protein, mean ± SEM, and lipid
peroxidation, In (B), TBARS assay is shown; nmol malondialdehyde (MDA) equivalent per mg protein was measured in 18-month-old SirT1 +/+ and / mice
brains.
(C and D) Calorie restriction does not extend life span of SirT1/mice. In (C), survival curves are shown for SirT1 +/+ (n = 16), +/ (n = 15),/mice (n = 14) on
ad-lib diet (p < 0.05, log-rank test). In (D), survival curves are shown for SirT1 +/+ (n = 13), +/ (n = 18),/ (n = 12) mice on 40% reduced-calorie diet (p < 0.001,
log-rank test). Mice were two to five months old at the onset of CR.
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SirT1 Sensitizes Neurons by Activating IRS-2/ERKprotect against aging (Cohen et al., 2004; Guarente, 2005). How-
ever, others have proposed that sirtuins are not required for the
effects of CR on life span (Hansen et al., 2007; Kaeberlein et al.,
2004; 2006; Lee et al., 2006). Our previous results in yeast sug-
gested that the lack of Sir2 can also increase resistance to stress
and extend further the chronological life span of calorie-re-
stricted cells or yeast also lacking components of the Ras/
cAMP/PKA or Sch9 pathway (Fabrizio et al., 2003, 2001, 2005;
Longo and Kennedy, 2006). In agreement with our results in
S. cerevisiae, here we found that inhibition of SirT1 reduces
IGF-I signaling and increases the resistance of mammalian cells
to oxidative stress. Our data indicate that SirT1 increases insu-
lin/IGF-I signaling in part by deacetylating IRS-2, which pro-
motes its phosphorylation. These posttranslation modifications
in IRS-2 are followed by Ras/ERK activation and sensitization
of primary rat neurons to oxidative stress. Inhibition of Ras/
Mek1/ERK1/2 activity was sufficient to protect the neurons
against oxidative stress. Whereas the level of markers of oxida-
tive damage was reduced in the brain of SirT1/ mice com-
pared to controls, these apparently protective effects were not
sufficient to counterbalance the positive effects of SirT1 as evi-
dent from the reduced mean life span of the homozygote KO
mice under both ad lib or CR diets. These results are consistent
with the existence of a pro-oxidative stress role for mammalian
SirT1 and Ras similar to that described for Sir2 and Ras in
S. cerevisiae but confirm that sirtuins can play both positive
and negative roles.
SirT1 was originally identified as a histone deacetylase. Con-
sistent with this function, it was found to be localized in the nu-
cleus in numerous studies (Michishita et al., 2005). Recently,
however, Tanno et al. (2007) examined different tissues and
found SirT1 predominantly localized to the cytosol in mouse
brain tissue. We checked SirT1’s localization in the brain. We
performed sucrose-gradient centrifugation to separate the brain
tissue into nuclear, cytosolic, andmembrane fractions. Immuno-
blots with these fractions indicate that SirT1 lies in both the
nucleus and the cytosol with the preference of cytosol in postna-
tal-day-3 brain, while SirT1 is almost exclusively retained in the
cytosol in the adult brain. This is in line with increasing evidence
pinpointing SirT1 as exhibiting cytosolic localization (Jin et al.,
2007; Kim et al., 2007; Tanno et al., 2007; Zhang, 2007). Besides
histones, various transcription factors have been identified as
substrates for SirT1. SirT1-mediated deacetylase activity on
these substrates seems to occur in the nucleus.
It has been proposed that SirT1 plays an antiaging role in
mammals by deacetylating and activating FOXO (forkhead tran-
scription factors class O) (Brunet et al., 2004; Kobayashi et al.,
2005). Similarly, SIRT1 exhibits antagonistic effects of insulin
on PGC-1a in gluconeogenesis (Rodgers et al., 2005). On the
other hand, evidence is also accumulating in support of a syner-
gic relationship between Sir2 and insulin/IGF-I. SirT1 was shown
to increase the release of insulin or improve insulin sensitivity
(Bordone et al., 2006; Moynihan et al., 2005; Sun et al., 2007).
Moreover, SirT1 lowered the expression of IGF-binding proteins
(IGFBP), a secreted inhibitory modulator of IGF function (Yang
et al., 2005), and SirT1 knockout mice have increased expres-
sion of IGFBP1 (Lemieux et al., 2005). In agreement with these
results, knockdown of liver SirT1 in mice reduced blood glucose
concentration (Rodgers and Puigserver, 2007).In our previous study in S. cerevisiae, the deletion of SIR2 in-
creased further the resistance of mutants lacking sch9 (homolo-
gous to S6 kinase and Akt) to heat shock and oxidative stress but
did not increase the resistance of mutants with defects in the
Ras/cAMPpathway raising the possibility that Sir2 and Ras func-
tion in the same pathway (Fabrizio et al., 2005; Longo and Ken-
nedy, 2006). Although a Ras/cAMP/PKA pathway has not been
described in mammalian cells, we provide a mechanism linking
SirT1 activity, the IGF-I/IRS-2/Ras/ERK pathway, and stress re-
sistance in mammalian cells. Our results suggest that inhibition
of SirT1 downregulates insulin/IGF-I-dependent activation of
ERK1/2 in part through decreased IRS-2 phosphorylation and
decreased Ras activation. These results are consistent with find-
ings that Ras induces premature replicative senescence in pri-
mary mammalian cells and that SirT1-deficient mouse em-
bryonic fibroblasts (MEFs) have a dramatically extended
replicative life span (Chua et al., 2005; Serrano et al., 1997). As
expected if SirT1 acts upstream of Ras, SirT1 was not required
for Ras-dependent accelerated replicative senescence (Chua
et al., 2005). Thus, it is possible that inhibition of IRS-2 upstream
of Ras is responsible for this effect of SirT1 deficiency on replica-
tive senescence. Interestingly, the PI3K/Akt pathway, another
major effector downstream of IRS-2, was unaffected by SirT1 in-
hibition— although overexpression of SirT1 was reported to in-
crease Akt activation under insulin-resistant conditions but not
under normal conditions (Sun et al., 2007). In contrast, only the
ERK1/2 pathway, but not the PI3K/Akt pathway, appears to be
affected by SirT1 inhibition in our system. These differences
may be explained by the observation that in some organs, IRS
proteins mediate the effects of insulin through PI3K whereas in
other tissues, they activate ERK signaling (Byron et al., 2006;
Huang et al., 2005). These imply that the coupling of IRS to the
downstream signaling may depend on the cell type or other en-
vironmental factors. The effect of SirT1 on IRS-2 may have im-
portant implications considering that brain Irs-2/ mice live
longer (Taguchi et al., 2007).
ERK1/2 is crucial for oxidative stress. ERK-signaling cascade
is known to be activated by oxidative stress (Gaitanaki et al.,
2003; Guyton et al., 1996; Zhang et al., 1998) and to exhibit
dual effects on cell death depending on its kinetics, duration, in-
tensity, and context of its activation (Chu et al., 2004). It has been
shown to promote cell survival under some conditions (Cheung
and Slack, 2004), while it increases the sensitivity to oxidative
stress under other conditions. Inhibition of ERK abrogates cell
death induced by H2O2 in pancreatic cancer cells (Osada
et al., 2008) and protects against glutamate-induced neuronal
death (Satoh et al., 2000). Our results suggest that SirT1 inhibi-
tion protects neurons by decreasing Ras/ERK signaling and pro-
vide evidence for the proaging role of the Ras/ERK pathway
downstream of IGF-I, analogously to that of the Ras pathway
in S. cerevisiae. In agreement with our present results, a reduc-
tion in brain IRS-2 increased the life span of mice and stabilized
MnSOD (manganese superoxide dismutase) activity after fasting
(Taguchi et al., 2007). These results in brain Irs-2+/ mice are
also consistent with our results in S. cerevisiae showing that
MnSOD is required for life-span extension in both mutants with
defects in SCH9 or RAS/cAMP signaling (Fabrizio et al., 2003).
Numerous studies point to SirT1 as a key regulator of cell sur-
vival in response to stress. It exhibits both pro- and antisurvivalCell Metabolism 8, 38–48, July 2008 ª2008 Elsevier Inc. 45
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tered p53-dependent apoptosis caused by etoposide in MEFs
(Luo et al., 2001). In an ALSmousemodel, SirT1 rescued neurons
(Kim et al., 2007). However, SirT1 can also exacerbate cell death.
As described earlier, SirT1 KO MEFs showed higher replicative
life spans under chronic, sublethal oxidative stress (Chua et al.,
2005). SirT1 also sensitized HEK293 cells to TNFa-induced apo-
ptosis (Yeung et al., 2004). Many factors may contribute to the
seemingly contradictory effects of SirT1. First, different nutrient,
growth, or stress signals may be sensed by SirT1 and integrated
into divergent outputs. Second, SirT1’s subcellular localization
may play a role in its regulation of cell death. Some studies sug-
gest that cytoplasm-localized SirT1 may promote apoptosis (Jin
et al., 2007; Zhang, 2007), while the antiapoptotic effect may
come only from nuclear-localized SirT1 (Tanno et al., 2007).
Third, SirT1 has a wide array of targets which may become pref-
erentially (de)activated in different contexts. Deacetylation of p53
and FOXO contributes to the prosurvival effect of SirT1 (Brunet
et al., 2004; Langley et al., 2002; Motta et al., 2004), while that
of NF-kB and p19ARF mediate the prodeath effect (Chua et al.,
2005; Yeung et al., 2004). It is possible that these transcription
factors are also implicated in the increased protection in
neurons with reduced SirT1 and ERK activity.
The detection of lower oxidative stress in the brain of SirT1
KO mice is consistent with our cell-culture data. The reduced
production of hydrogen peroxide by mitochondria and major
changes in electron transport and leakage in SirT1 KO mice re-
cently shown by McBurney and colleagues (Boily et al., 2008)
may explain part of the protective effect observed after SirT1 in-
hibition. Yet we cannot conclude that SirT1 promotes oxidative
damage in all organs in vivo, as SirT1 may play vastly different
roles in various organs. For example, Alcendor et al. (2007) re-
ported the beneficial effect of SirT1 overexpression in the heart
against oxidative stress, although they showed that this antiox-
idant effect becomes a pro-oxidant effect at a higher overex-
pression level. In agreement with the very different roles of
SirT1, here we show that the pro-oxidative stress role of SirT1
in neurons and in the mouse brain is not translated into a longer
life span. In fact, SirT1 KO mice live shorter than wild-type con-
trols under both normal and CR diets (Figure 6). Thus, differently
from our studies in yeast, we did not find that CR further ex-
tends the life span of SirT1 KO mice, which is consistent with
a recent report (Boily et al., 2008). Considering that SirT1 +/
mice display a normal mean life span and that SirT1/ mice
have severe developmental defects including a dwarf pheno-
type (McBurney et al., 2003), it is likely that these defects con-
tribute to shortening the life span independently of the rate of
aging. A brain-specific SirT1 KO mouse model may provide
further clues.
In summary, this study suggests that SirT1 can contribute to
oxidative damage in mammals by activating IRS-2/Ras/ERK sig-
naling downstream of insulin/IGF-I receptors but also plays
a number of roles important for normal growth and life span
(McBurney et al., 2003; Moynihan et al., 2005; Picard et al.,
2004). There has been a keen interest in developing SirT1 activa-
tors for human consumption. Our studies implicating SirT1 in
both pro-aging and protective functions in yeast andmammalian
cells suggest that additional studies should be carried out before
SirT1 activators are considered for chronic use.46 Cell Metabolism 8, 38–48, July 2008 ª2008 Elsevier Inc.EXPERIMENTAL PROCEDURES
Materials
Antibodies for SirT1 (07-131), IRS-2 (06-506), and phosphotyrosine 4G10 (05-
321), NeuN (MAB377), GluR2/3 (AB1506), Ras activation assay kit (17-218),
and SirT1 deacetylase (17-370) were from Millipore. Antibodies for phospho-
p44/42 MAP kinase (Thr202/Tyr204;9101), p44/42 MAP kinase (9102), IRS-1
(2382), IRS-2 (4502), and acetylated-lysine (AcK103;9681) were from Cell Sig-
naling (Danvers, MA). Anti-GAPDH (ab9484) was from Abcam (Cambridge,
MA). Anti-V5 (R960-25) was from Invitrogen (Carlsbad, CA). Other chemicals
were from Sigma-Aldrich (St. Louis, MO). U6Pro-SirT1-siRNA is a plasmid
carrying SirT1 siRNA sequence of GAAGTTGACCTCCTCATTGT. SirT2DN
(pEGFP-C1-hSIRT2 N168A) was from Dr. Eric Verdin. V5-SIRT1 was from
Dr. Marty Mayo.
Cell Culture
Neurons from E18 rat cortex were dissociated in neurobasal medium supple-
mented with 0.5 mM glutamine, 25 mM glutamate and B-27, and plated at
3 3 104/well in 96-well plates for viability assays, at 105/well in 6-well plates
for immunostaining or 5 3 105 for immunoblotting, at 3 3 106 onto 10 cm
dishes for activity assay or immunoprecipitation. They were maintained in
neurobasal medium supplemented with B-27 and glutamine until 5–7 DIV for
transfection or 10–14 DIV for treatments. Neurons for MTT were pretreated
with SirT1 inhibitor for 48 hr prior to exposure to H2O2 or menadione for
24 hr in Eagle’s minimal essential medium supplemented with 21 mM glucose,
5% fetal bovine serum, and 5% horse serum.
Negative control and SirT1 siRNA (SirT1 target sequence: AAGTGCCT
CAAATATTAATAA) were from QIAGEN. The sequence specificity of siRNA
against rat SirT1 was verified by a genome-wide search against the rat build
four-genome database (8,014 sequences; 5,387,086,425 total letters, NCBI).
At least 2 nt differences were found in the nearest match, and no predicted
rat sirtuins (SIRT2-7) were in the top 20 hits. On 5 DIV, rat cortical neurons
were transfected with 25 nM control or SirT1 siRNA using HiPerFect Transfec-
tion Reagent. Two days later, cells were treated with chemicals or collected
for assays. Neurons were transfected with Clontech CalPhos Mammalian
Transfection Kit. HEK293 cells were transfected with Lipofectamine reagent
(Invitrogen).
SirT1 Deacetylase Activity
SirT1 deacetylase activity was measured using fluorometric SIRT1 Assay Kit
(Sigma CS1040) per manufacturer instructions except that 1 mM trichostatin
A was also added to the reaction. Fluorescence intensity at 444 nm (excitation
355 nm) was recorded and normalized to micrograms of protein and values
represented as percent of control.
Viability
Cell survival was measured by 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-
tetrazolium bromide (MTT) assay. Absorptions at 570 nm were normalized to
control and three to four wells were used for each condition per experiment.
Data from three independent experiments were averaged and shown as
mean ± SEM. LDH assay was performed with CytoTox 96 Non-Radioactive
Cytotoxicity Kit (Promega, Madison, WI). Data from three independent exper-
iments are shown as mean ± SEM and normalized to control. Apoptosis was
measured with Cell Death Detection ELISAPLUS kit (Roche, Indianapolis, IN).
Data from 10 wells from three independent experiments are shown as mean
± SEM and normalized to control. In Live/Dead Assay (Invitrogen L3224), cells
were stained with 2 mM calcein AM (green fluorescent due to esterase in living
cells) and 2 mMethidium homodimer 1 (EthD-1, red fluorescent once binding to
DNA) for 10 min at 37C followed by washing with HBSS and observation un-
der the microscope. In each experiment, two coverslips were used for each
condition and four random fields were captured for each coverslip. Live (green)
and dead (red) cells were counted from three independent experiments. A por-
tion of a representative image is shown for each condition.
Immunocytochemistry
Immunocytochemistry was performed with standard protocol as previously
described (Xu et al., 2007).
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Cells or tissue were homogenized in 1% SDS, 10 mM Tris (pH 7.4), protease
inhibitor cocktail, 1 mM Na3VO4, 1 mM NaF, followed by boiling at 95
C for
5 min and centrifugation at 14,000 rpm at 4C for 30min. Equal amounts of su-
pernatant protein were resolved on SDS-PAGE and immunoblotted following
standard procedures. Blots were quantified with NIH image. For coIP, cells
were lysed in modified radioimmunoprecipitation buffer and lysates incubated
with 5 mg of anti-V5 or control IgG and protein was pulled down by protein A
agarose. For IP, cells were lysed in modified RIPA containing 1 mM TSA and
5 mM nicotinamide and incubated with IRS-1 or IRS-2 antibodies; protein
was pulled down by protein A agarose. Ras-activation assay (Upstate
17-218) was performed per manufacturer’s instructions.
In Vitro Deacetylation
IRS-2 was immunoprecipitated from HEK293 cells, and an equal amount of
IRS-2 was incubated with different amounts of SirT1 deacetylase (0, 1, 2 mg)
in 1 mM NAD, 25 mM Tris (pH 8.0), 137 mM NaCl, 2.7 mM KCl, 1 mM
MgCl2, and 0.2 mMDTT for 1.5 hr at RT. The reaction was stopped by addition
of denaturing buffer and subjected to western blotting.
Animals
Wild-type C57BL/6J male (3-day- and 2-month-old) mice were used for brain
fractionation. SirT1+/+, +/, and / genotypes have been described previ-
ously (McBurney et al., 2003). Mice were deeply anesthetized with isoflurane
followed immediately by decapitation, and brains (and hippocampi) were
collected right away. In life-span studies, ad-libitum mice were fed NIH-31
standard feed while CRmice were fed daily with NIH31/NIA-fortified food con-
taining 60% of calories consumed by ad-libitum mice. Water was available ad
libitum for all mice.
Brain Fractionation
Forebrain homogenates were separated into nuclear, cytosol, and membrane
fractions through sucrose-gradient centrifugation. The forebrain was homog-
enized in chilled buffer containing 0.32 M sucrose, 10 mM HEPES (pH 7.4), 2
mM EDTA, protease inhibitors, and phosphatase inhibitors and centrifuged
at 10003 g for 15 min to yield the nuclear fraction pellet. The supernatant
was then centrifuged at 200,0003 g for 15 min to yield cytosol in the superna-
tant. The resulting pellet was resuspended and centrifuged four more times to
obtain the membrane fraction.
Determination of Oxidative Stress
Half brain minus cerebellum (HFB) was homogenized in 50 mM phosphate
buffer (pH7.4) and centrifuged to yield supernatant for assaying for protein car-
bonyl content with OxiSelect Protein Carbonyl ELISA Kit (CellBiolabs Inc., San
Diego, CA). For lipid peroxidation, HFB was homogenized in TBARS homoge-
nization buffer and subjected to TBARS assay as previously described (Liu
et al., 2003).
Statistical Analysis
Student’s t test was used to compare two groups. One-way ANOVA was used
to compare multiple groups with Turkey’s test as posthoc test. Groups were
determined significantly different when p < 0.05.
SUPPLEMENTAL DATA
Supplemental Data include seven figures and can be found online at http://
www.cellmetabolism.org/cgi/content/full/8/1/38/DC1/.
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